Whalegun
Home

Amgen AMGN spent $1.9M on lobbying in Q2 2023 · Health Issues, Medicare and 2 more issues

Trade details

Type
Lobbying report
Amount
$1,950,000
Quarter
Q2 2023
Stock
Amgen AMGN
Client
Amgen
Reported
23/07/20

Down 30.4% from last quarter

What else happened in Amgen around then

Filed or reported within 30 days of the trade day · 23/05/31~23/07/30

Amgen's other lobbying reports

  • Amgen

    LobbyingAmgen

    Under $5,000

    Reported 07/28

  • Amgen

    LobbyingAmgen

    Under $5,000

    Reported 07/21

  • Amgen

    LobbyingAmgen

    $50K

    Reported 07/20

  • Amgen

    LobbyingAmgen

    $80K

    Reported 07/20

  • Amgen

    LobbyingAmgen

    $60K

    Reported 07/20

Amgen AMGN spent $1.9M on lobbying in Q2 2023 · Health Issues, Medicare and 2 more issues | Whalegun